Transaction #25464 · Form 4 · 0001140361-25-046788
Roivant Sciences Ltd. · Stock award · Common Shares
Roivant Sciences Ltd. · Transacted December 23, 2025 · Filed December 29, 2025
What does this filing report?
An SEC Form 4 filing for Roivant Sciences Ltd. records a stock award involving Common Shares on December 23, 2025. The reported quantity was 175,380. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Roivant Sciences Ltd.
- Company CIK
- 0001635088
- Security type
- Non-derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 175,380
- Reported price
- 22.45 · See footnotes
- Reference value
- 3,937,281
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 13,911,927
- Ownership description
- Not reported
- SEC acceptance time
- Dec 29, 2025, 9:00 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Torti Frank ↗
President and Vant Chair
CIK 0001647805
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Represents Common Shares received in exchange for shares of a subsidiary of the Issuer. The per Common Share price represents the closing price of the Issuer's Common Shares on the date of the exchange.
- F2
- The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $22.45 to $22.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range.
- F3
- Represents a sale of Common Shares only to cover estimated taxes due in connection with the exchange described in footnote 1.
- F4
- The Reporting Person donated 110,489 Common Shares to a donor advised fund, which will use the gifted Common Shares for charitable purposes.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.